Infectologia

Bacteriemia por S. aureus complicada e não complicada: uma pesquisa internacional Delphi entre especialistas em doenças infecciosas sobre definições e tratamento.

31 Mar, 2022 | 13:34h

Complicated and uncomplicated S. aureus bacteremia: an international Delphi survey among infectious diseases experts on definitions and treatment – Clinical Microbiology and Infection

M-A | Anormalidades do parênquima pulmonar após internação por COVID-19 e pneumonite viral.

31 Mar, 2022 | 13:29h

Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis – Thorax

Estudo de coorte | Variações socioeconômicas determinam a apresentação clínica, a etiologia e o desfecho da endocardite infecciosa.

31 Mar, 2022 | 12:56h

Socio-Economic Variations Determine the Clinical Presentation, Aetiology and Outcome of Infective Endocarditis: a Prospective Cohort Study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) Registry – European Heart Journal – Quality of Care and Clinical Outcomes

Comentário no Twitter

Infective #endocarditis – do socio-economic factors impact presentation and prognosis? Unfortunately yes, according to data from EURO-ENDO Registry: https://t.co/JdKM5igihR #CVD #EHJQCCO @cpgale3 @diogoasantosfer pic.twitter.com/pkclJdRsdU

— European Society of Cardiology Journals (@ESC_Journals) March 28, 2022

Opinião | Vacinação global deve ser mais rápida.

29 Mar, 2022 | 15:14h

Global vaccination must be swifter – Nature

Miocardite e pericardite após vacinação contra COVID-19: diretriz para profissionais da saúde.

29 Mar, 2022 | 15:13h

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Conteúdos relacionados:

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

Diretrizes brasileiras para o tratamento de pacientes ambulatoriais com COVID-19 suspeita ou confirmada.

29 Mar, 2022 | 15:10h

Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT) – The Brazilian Journal of Infectious Diseases

Estudo antes-e-depois | Efetividade da implementação de cuidados preventivos com o cateter urinário em pacientes com fratura de quadril.

29 Mar, 2022 | 14:44h

Effectiveness of implementing a preventive urinary catheter care bundle in hip fracture patients – Journal of Infection Prevention

Comunicado de imprensa: Catheter infections went down after more preventive efforts – University of Gothenburg

Revisão | Antibioticoterapia curta e oral para infecção do pé diabético.

29 Mar, 2022 | 14:41h

Short and oral antimicrobial therapy for diabetic foot infection: a narrative review of current knowledge – Journal of Bone and Joint Infection

Estudo de coorte | Coinfecção SARS-CoV-2 e influenza, vírus sincicial respiratório ou adenovírus está associada com mortalidade aumentada.

29 Mar, 2022 | 14:20h

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses – The Lancet

Comentário: Patients with Covid and flu double the risk of dying, say scientists – The Guardian

Comentário do autor no Twitter (fio – clique para saber mais)

In our latest paper from ISARIC4C we show that covid and flu together is a dangerous combination: 4x greater odds of needing a ventilator; 2x greater odds of dying. So we should test more widely for flu, and if you are offered a vaccine, please take it https://t.co/gI2GQnTRQH

— Kenneth Baillie (@kennethbaillie) March 25, 2022

Moderna solicita que o FDA autorize o uso de sua vacina contra Covid-19 em crianças de 6 meses a 6 anos de idade.

29 Mar, 2022 | 14:19h

Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years – STAT